An analysis of pharmaceutical care for critical patients of an adult Intensive Care Unit
DOI:
https://doi.org/10.1590/s2175-97902023e21345%20%20Keywords:
Pharmaceutical Services, Pharmacy Service, Hospitals, Evidence-Based Pharmacy Practice, Patient safety, Intensive care unitsAbstract
This work analyzed the pharmacotherapeutic problems identified by the clinical pharmacist in an intensive care unit (ICU) and the acceptance of pharmaceutical interventions in solving these problems. This is a descriptive cross-sectional retrospective study, carried out in the adult ICU of a public hospital. All patients hospitalized during the study period had their pharmacotherapy monitored and those whose stay at the ICU lasted less than 24 hours were excluded. The pharmacotherapeutic problems were classified according to type, cause, acceptability/implementation, mode of intervention, outcome and related pharmacotherapeutic group. 302 patients were followed up and 350 pharmacotherapeutic problems were identified. Most of them were classified as unnecessary drug-treatment (n=186; 53.1%). The most frequent causes were excessive drug administration (n=181; 97.3%), and antimicrobials was the main group of drugs associated to that type of problem. 350 pharmaceutical interventions were performed, highlighting “prescriber informed only” (n=178; 50.9%), with an average acceptability of 90.7%, with those carried out on site being more effective (93.4%). The number of pharmacotherapeutic problems that were totally solved was 282 (80.6%). Clinical pharmacy activities in the ICU identified, prevented and corrected pharmacotherapeutic problems, contributing to the optimization of pharmacotherapy in aspects related to the need, efficacy and safety of treatments.
Downloads
References
Adriano LS, Ibiapina JR, Romero NR, Lima AMA, Ponciano MAS, Fonteles MMF. Medicantion errros in critical patiente during medication reconciliation: analyses and clinical management. Braz J Pharm Sci. 2022;58:1-9
Aguiar KS, Santos JM, Cambrussi MC, Picolotto S, Carneiro MB. Patient safety and the value of pharmaceutical intervention in a cancer hospital. Einstein (Sao Paulo). 2018;16(1):1-7.
Belaiche S, Goulois S, DeBarranger E, Odou P, Balagny S, Décaudin B. Clinica pharmacist and pharmaceutical interventions in HBH unit: a French observational study. Acta Clin Belg. 2021;76(4):258-263.
Brasil. Ministério da Saúde. Documento de referência para o Programa Nacional de Segurança do Paciente [internet]. Ministério da Saúde, 2014. [citado 2021 Mai 4]. 40 p.: il. Disponível em: Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/documento_referencia_programa_nacional_seguranca.pdf
» https://bvsms.saude.gov.br/bvs/publicacoes/documento_referencia_programa_nacional_seguranca.pdf
Brasil. Ministério do Planejamento, Orçamento e Gestão, Instituto Brasileiro de Geografia e Estatística-IBGE. Pesquisa nacional por amostra de domicílios. Um Panorama da Saúde no Brasil: Acesso e utilização dos serviços, condições de saúde e fatores de risco e proteção à saúde 2008 [internet]. IBGE, Rio de Janeiro, 2010. [citado em: 2021 mai 4]. Disponível em: Disponível em: https://biblioteca.ibge.gov.br/visualizacao/monografias/GEBIS%20-%20RJ/panorama.pdf
» https://biblioteca.ibge.gov.br/visualizacao/monografias/GEBIS%20-%20RJ/panorama.pdf
Cano FG, Rozenfeld S. Adverse drug events in hospitals: a systematic review. Cad Saude Publica. 2009;25(Suppl. 3):S360-72.
Conselho Nacional de Saúde (Brasil). Resolução nº 466, de 12 de dezembro de 2012. Brasília, 2012 [citado 2021 Mar 5]. Disponível em: Disponível em: http://www.conselho.saude.gov.br/web_comissoes/conep/index.html
» http://www.conselho.saude.gov.br/web_comissoes/conep/index.html
Conselho Regional de Farmácia do Estados de São Paulo (CRF-SP). Departamento de Apoio Técnico e Educação Permanente. Comissão Assessora de Farmácia Clínica. Farmácia Clínica. [internet] Conselho Regional de Farmácia do Estado de São Paulo, 2019. 2ª ed. [citado em 2021 mai 4]. 56 p. Disponível em: Disponível em: http://portal.crfsp.org.br/images/190919_cartilha_fc_GM_s04.pdf
» http://portal.crfsp.org.br/images/190919_cartilha_fc_GM_s04.pdf
Dias D, Wiese LPL, Pereira EM, Fernandes FM. Evaluation of Pharmaceutical Clinical Interventions in the Icu of a Public Hospital of Santa Catarina. Rev Bras Farmácia Hosp Serv Saúde. 2018;9(3):1-5.
Figueiredo TWB, Da Silva LAA, Brusamarello T, Oliveira ES, Pontes L. Types, causes and intervention strategies facing medication erros: na integrative review. Rev Enferm Atenção Saúde [online]. 2018;7(2):155-175.
Fonseca CL, Obreli-neto PR, Baldoni AO, Reis TM, Rodrigues JPV, Pereira LRL, et al. A Farmácia Clínica no Brasil: uma revisão integrativa. Rev Bras Farmácia. 2017;98:1826-44.
Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: An intervention study. Crit Care. 2010;14(5):1-11.
Kohn LT, Corrigan JM, Donaldson MS. To Err is Human: Building a Safer Health System. [internet]. Institute of Medicine. vol. 12. Washington DC, 2000. [citado em: 2021 mai 4]. Disponível em: Disponível em: https://pubmed.ncbi.nlm.nih.gov/25077248/
» https://pubmed.ncbi.nlm.nih.gov/25077248/
Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. J Am Med Assoc. 1999;282:267-70.
Leguelinel-Blache G, Arnaud F, Bouvet S, Dubois F, Castelli C, Roux-Marson C, et al. Impact of admission medication reconciliation performed by clinical pharmacists on medication safety. Eur J Intern Med. 2014;25(9):808-814.
Mailman JF, Semchuk W. Pharmacists’ roles in critical care: Environmental scan of current practices in Canadian intensive care units. Can J Hosp Pharm. 2018;71(3):215-6.
Marques TC, Silva ROS, dos Santos Júnior GA, de Jesus Júnior FC, Silvestre CC, Rocha KSS, et al. Evaluation of process indicators of a medication review service between pharmacists and physicians. J Eval Clin Pract. 2019;26(5):1448-56.
Martins UCM, Ramalho-de-Oliveira D, Nascimento MMG, Nascimento YA, Oliveira GCB, Cid AS, et al. Potentially inappropriate medication use i a comprehensive therapy management service: clinical outcomes and interventions. Braz J Pharm Sci. 2022;58:1-11.
Oliveira ABF, Dias OM, Mello MM, Araújo S, Dragosavac D, Nucci A, et al. Fatores associados à maior mortalidade e tempo de internação prolongado em uma unidade de terapia intensiva de adultos. Rev Bras Ter Intensiva. 2010;22(3):250-6.
Phamaceutical Care Network Europe (PCNE). PCNE Classification for Drug related problems V9.00. [internet]. Pharmaceutical Care Network Europe Association (PCNEA), 2019 [citado: 2021 mai 4]. 10 p. Disponível em: Disponível em: https://pcne.org/upload/files/334_PCNE_classification_V9-0.pdf
» https://pcne.org/upload/files/334_PCNE_classification_V9-0.pdf
Pilau R, Hegele V, Heineck I. Atuação do Farmacêutico Clínico em Unidade de Terapia Intensiva Adulto: Uma Revisão da Literatura. Rev Bras Farm Hosp Serv Saúde. São Paulo 2014;5(1):19-24.
Silva ACSE, Sousa DSC, Perraud EBC, Oliveira FRA, Martins BCC. Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results. Einstein (Sao Paulo). 2018;16(2):1-7.
Siqueira LF, Gomes Neto LC, Gonçalves KAM. Atuação do farmacêutico clínico no âmbito hospitalar/Clinical pharmacist’s performance in the hospital environment. Braz J Health Review. 2021;4(6):25467-25485.
Weant KA, Cook AM, Armitstead JA. Medication-error reporting and pharmacy resident experience during implementation of computerized prescriber order entry. Am J Health Syst Pharm. 2007;64(5):526-30.
World Health Organization Collaborating Centre For Drug Statistics Metodology (WHOCC). Guideline for ATC Classification and DDD assignment 2021. [internet]. Oslo, Norway: WHOCC, 2020. 24rd ed. [citado 2021 mai 4] 249 p. Disponível em: Disponível em: https://www.whocc.no/filearchive/publications/2021_guidelines_web.pdf
» https://www.whocc.no/filearchive/publications/2021_guidelines_web.pdf
Zhang P, Lv D, Zhao J, Sun S, Li L, Liao Y. Evaluation of Pharmaist´s interventions on drug-related problems and drug costs in patients with cancer pain. Int J Clin Pharm. 2021;43(5):1274-1282.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
